Global Chondroplasty Market Size, Share, Forecast Report, 2020-2027

Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in the joint such as knee joint.
In healthy condition articular cartilage which covers the end of the bones that form the joint is smooth and provides low friction surface for the joint structures. However in conditions such as arthritis, trauma, injuries etc. it becomes rough and damaged causing pain and swelling. Joint cartilage once damaged naturally heals poorly in most cases. Chondroplasty is performed to decrease complications, risks, and recovery time. The purpose of Chondroplasty is to remove away the damaged joint surface. The success rate of chondroplasty is about 70%. The drawback of Chondroplasty is that the new growth is not true cartilage/hyaline. Traditional chondroplasty is done by mechanical means such as shavers but has deleterious effects such as fine surface fibrillation, subchondral bleeding and formation of fibrocartilage, which is not as functional as normal hyaline cartilage. Radiofrequency ablation chondroplasty is the latest development and the most non-invasive chondroplasty. It uses radiofrequency waves for welding cracks together in the cartilage.
The market drivers for chondroplasty are increasing geriatric population, growing screening for joint and orthopaedic defects, rising number of accidents & trauma cases, growing sports culture, rising awareness and growing income of people.
The market restraints are the risks associated with surgery such as bleeding, pain, infection, cost considerations, poor healing in some cases, etc.
The global chondroplasty market is expected to reach US$ 14.8 billion by 2023, and the market is projected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.
Segments:
The global chondroplasty market has been segmented on the basis of types, anatomy, instruments and end users.

Based on types, the market has been segmented as radiofrequency ablation chondroplasty, abrasion chondroplasty, atellar chondroplasty, meniscal repair, tissue removal, and others.

Based on anatomy, the market has been segmented as knee, shoulder, hip, and others.

Based on instruments, the market has been segmented as shavers, RF devices, arthroscope and others.

Based on the end users, the market has been segmented as hospitals & orthopedic clinics, academic & research and others.
Key Players in the Global Chondroplasty Market
Some of key players profiled in the report are B. Braun Melsungen AG, NuOrtho Surgical, Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Nebula Inc., Gpcmedical, Osiris Therapeutics, Inc., Sklar Surgical Instruments, Stryker Corporation, and others.